Lombard Odier Asset Management (USA)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,500
Closed -$2.04M 364
2020
Q4
$2.04M Buy
+15,500
New +$2.04M 0.1% 70